Could you provide a comprehensive, chapter-by-chapter overview of pharmacology?

Pharmacology Overview: Core Principles and Clinical Application

I cannot provide a comprehensive chapter-by-chapter pharmacology textbook as requested, as the evidence provided does not contain structured textbook content covering all pharmacology chapters. However, I can synthesize the key pharmacological principles from the available guidelines and research.

Fundamental Pharmacology Concepts

Pharmacology consists of two essential domains: pharmacokinetics (what the body does to the drug) and pharmacodynamics (what the drug does to the body). 1, 2 Understanding these principles is critical for rational drug therapy and predicting drug behavior in clinical practice.

Pharmacokinetics: ADME Principles

Pharmacokinetics encompasses four key processes 3, 4, 1:

Absorption:

• Oral drugs are absorbed primarily by passive diffusion
• In older adults, absorption may be delayed but total absorption remains unchanged
• First-pass metabolism and gut wall transporters affect bioavailability of specific drugs (diltiazem, propranolol, simvastatin, verapamil) 4

Distribution:

• Volume of distribution (Vd) determines drug concentration in tissues
• Hydrophilic drugs (digoxin, theophylline) have decreased Vd in elderly due to reduced body water
• Lipophilic drugs (amiodarone, benzodiazepines, lidocaine) have increased Vd and prolonged half-life 4
• Plasma protein binding affects free drug concentration, particularly for highly albumin-bound drugs

Metabolism:

• Phase I reactions (CYP450-mediated oxidation, reduction, hydrolysis) decrease 20-50% with age
• Phase II conjugation reactions remain relatively preserved
• CYP3A4, 2D6, and 2C19 are the primary isoforms involved in drug metabolism 4
• Drug-drug interactions commonly occur through CYP450 inhibition or induction

Excretion:

• Renal clearance is the most important cause of adverse drug reactions in elderly
• Use CKD-EPI equation (creatinine-cystatin C) for accurate GFR estimation in older adults
• Serum creatinine may be falsely normal despite reduced renal function due to decreased muscle mass 4

Pharmacodynamics: Drug-Receptor Interactions

Pharmacodynamics describes the concentration-effect relationship at the drug's site of action 1, 2:

• Dose-response relationship: The fundamental concept linking drug concentration to clinical effect
• Receptor occupancy: Determines magnitude of pharmacological response
• Time-dependent vs. concentration-dependent killing: Critical for antimicrobial therapy 5
  • β-lactams exhibit time-dependent killing (T>MIC should be 40-50% of dosing interval)
  • Optimal killing occurs at 2-4× MIC; higher concentrations don't improve efficacy
  • Peak:MIC ratio and AUC:MIC ratio predict outcomes for concentration-dependent agents

Age-Related Pharmacological Changes

In older adults, multiple physiological changes significantly alter drug disposition 4:

• Decreased hepatic blood flow reduces clearance of high-extraction drugs (metoprolol, propranolol, verapamil)
• Reduced GFR (30-35% decrease) increases exposure to renally cleared drugs
• Decreased plasma albumin increases free fraction of highly protein-bound drugs
• 20-30% reduction in liver mass affects drug metabolism

Clinical Application: Medication Management

Polypharmacy Assessment Algorithm 6, 7

Follow this stepwise approach to identify drug therapy problems:

1. Medication reconciliation: Create accurate list of what patient actually takes
2. Adherence assessment: Use Morisky Scale; review pill boxes and refill dates
3. Drug-drug interaction screening: Check for QT prolongation, bleeding risk, serotonin syndrome
4. Drug-disease interactions: Identify NSAIDs in heart failure/CKD, sulfonylureas in renal disease
5. Overtreatment identification: Find duplicates and additive toxicities
6. High-risk drug screening: Apply Beers criteria and STOPP/START criteria 7
7. Undertreatment assessment: Use START criteria for missed indicated therapies
8. Monitoring evaluation: Verify appropriate lab monitoring (TSH, INR, glucose)

Key Drug-Drug Interactions 8

Pharmacokinetic interactions (CYP3A4 pathway):

• Verapamil and diltiazem are substrates and inhibitors
• Verapamil inhibits P-glycoprotein, increasing dabigatran (bleeding risk) and digoxin levels (toxicity risk)

Pharmacodynamic interactions:

• Beneficial: RAS inhibitor + thiazide (minimizes hypokalemia); dihydropyridine CCB + RAS inhibitor (reduces edema)
• Harmful: ACEi + ARB (hyperkalemia risk); overlapping mechanisms increase adverse effects

Medication Optimization Principles 9, 6

For chronic conditions, prioritize:

• Once-daily dosing to maximize adherence 8
• Simplification of regimen complexity
• Cost-effective alternatives when appropriate
• Regular monitoring with clear go/no-go criteria 10

Deprescribing approach:

• Target medications without reasonable benefit
• Prevent high-risk combinations
• Reduce cost and complexity while maintaining beneficial therapy
• Use validated tools (Beers criteria, STOPP/START) to identify potentially inappropriate medications 6, 7

Common Pitfalls

• Creatinine-based GFR overestimation in elderly: Always use CKD-EPI creatinine-cystatin C equation 4
• Assuming normal renal function: Reduced muscle mass masks renal impairment
• Ignoring pharmacodynamic interactions: Focus extends beyond pharmacokinetic interactions
• Multiple daily dosing: Significantly reduces adherence compared to once-daily regimens 8
• Inadequate monitoring: Each medication requires specific safety and efficacy monitoring 6

The evidence provided does not support a complete chapter-by-chapter pharmacology textbook but emphasizes these core clinical principles essential for safe and effective medication management.